Uncover key drivers, emerging technologies, and competitive movements shaping the international normalized ratio (inr) test meter market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Automated Compounding Devices Market covering 2026–2035?
The automated compounding devices market has experienced significant growth over recent years. Projections indicate its expansion from $2.51 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this growth has stemmed from factors such as increasing hospital pharmacy workload, rising demand for sterile iv preparation, early adoption of tpn compounding automation, hospital initiatives to reduce compounding errors, and the expansion of inpatient medication therapy volumes.
The automated compounding devices market size is anticipated to experience robust expansion in the coming years. It is projected to reach $3.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period can be attributed to a heightened focus on medication safety compliance, increased investments in automated pharmacy technology, a rise in the outsourcing of sterile compounding services, the expansion of oncology and critical care drug compounding, and the growing integration of digital workflow and reporting systems. Significant trends expected during this period include the increasing adoption of automated compounding devices to reduce manual medication preparation errors in hospital and pharmacy environments, a rising demand for high-precision compounding of IV formulations, oncology drugs, and TPN solutions, a growing transition towards centralized and large-volume sterile compounding facilities within healthcare systems, an expanding application of automated workflow validation and barcode-based verification in compounding processes, and an increasing preference for compact, modular, and upgradeable automated compounding platforms for pharmacy operations.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Automated Compounding Devices Market?
An expanding volume of personalized medicines is projected to propel the automated compounding devices market forward. This medical strategy involves customizing healthcare choices, methods, interventions, and therapies to suit each patient’s unique attributes. The rise in personalized medicines can be attributed to enhanced genetic comprehension, distinct patient data, and supportive regulations. Automated compounding devices (ACDs) are vital in personalized medicine, facilitating the exact and precise creation of bespoke medication formulations designed for individual patient requirements. They automate the mixing of diverse pharmaceutical components in precise ratios, a fundamental step for developing customized treatments. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA cleared 16 novel personalized therapies for patients with rare diseases in 2023, an increase from six in 2022. Consequently, the growing availability of personalized medicines is boosting the expansion of the automated compounding devices market.
What Segments Are Identified Within The Structure Of The Automated Compounding Devices Market?
The automated compounding devices market covered in this report is segmented –
1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems
Which Trends Are Expected To Influence The Automated Compounding Devices Market In The Upcoming Years?
Major companies operating in the automated compounding devices market are focusing on AI-powered robotic compounding, specifically AI-enabled IV compounding platform systems that utilize artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with exceptional precision, real-time quality checks, and continuous oversight. For instance, in August 2025, Omnicell, a US-based health-technology company, launched an AI-enhanced upgrade to its IV compounding system, which is designed to improve both safety and accuracy in medication preparation. This updated system integrates advanced AI-based quality-assurance tools that constantly monitor compounding activities, automatically detecting and flagging any deviations from expected procedures. By introducing this level of automated oversight, Omnicell aims to reduce human error, enhance workflow efficiency, and support higher standards of medication quality in pharmacy operations.
Which Key Market Players Are Investing In Expansion And Innovation Within The Automated Compounding Devices Market?
Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report
Which Regions Are Poised For Strategic Growth In The Automated Compounding Devices Market?
North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Automated Compounding Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp
Browse Through More Reports Similar to the Global Automated Compounding Devices Market 2026, By The Business Research Company
Plastic Compounding Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/plastic-compounding-global-market-report
Compound Management Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/compound-management-global-market-report
Electronic Products Market 2026
https://www.thebusinessresearchcompany.com/report/electronic-products-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company